REDWOOD CITY, Calif., July 21, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. ((“Coherus” or the “Company”, NASDAQ:CHRS), today announced that effective July 20, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 187,000 shares of the common stock of the Company to…Read More
Coherus BioSciences Announces New Employment Inducement Grants Coherus BioSciences NASDAQCHRS
